NIH Institute Fit Guide: NIAID, NCI, NHLBI, NINDS, or NIGMS?

Choose the right NIH institute based on disease area, study design, and translational intent before proposal investment.

NIAID

  • Infectious disease, immunology, allergy, and global health security priorities
  • Strong fit for vaccines, diagnostics, antimicrobials, and pandemic preparedness
  • Often overlaps with BARDA for translational and countermeasure programs

NCI

  • Oncology-focused basic, translational, and clinical research programs
  • Strong fit when cancer biology, therapeutics, or prevention science is central
  • Reviewers expect rigorous study design tied to cancer-specific outcomes

NHLBI

  • Cardiovascular, pulmonary, blood, and sleep disorder research
  • Strong fit for device, therapeutic, and population-health programs in these domains
  • Emphasis on mechanistic clarity and clinical relevance to heart/lung disease

NINDS

  • Neurological and neurodegenerative disease research priorities
  • Strong fit for brain-computer interfaces, neural therapeutics, and CNS diagnostics
  • Reviewers expect strong rationale linking intervention to neurological endpoints

NIGMS

  • Basic biomedical science and cross-cutting methodological research
  • Strong fit for fundamental biology, computational methods, and training-linked programs
  • Less disease-specific than institute-focused R01 pathways

Velawolf recommendation

When institute fit is ambiguous, run a parallel fit assessment across two institutes and align study aims to the institute with the strongest mission overlap and review culture match.